Vinay Prasad

FDA Panel Recommends Monovalent JN.1 COVID Vaccine for Fall, Limits Use to High-Risk Groups

FDA Limits COVID-19 Vaccine Approvals to Older, High-Risk Groups

FDA Limits COVID-19 Shot Approval to Elderly, High-Risk Groups

Analysts Cut Targets for Sarepta, Korro Bio, Beyond Meat

Vinay Prasad Appointed FDA Vaccines Director Amid COVID Policy Criticism

Wall Street Ends Nine-Day Winning Streak as Oil Prices Plummet